Retatrutide, a new dual stimulator of the GLP-1 binding site and glucose-dependent released polypeptide (GIP) target, is showing promising outcomes in initial patient assessments . Ongoing research https://trackbookmark.com/story23166343/retatrutide-emerging-research-and-projected-medical-applications